Espoo, Finland

Anna-Elina Lehesjoki

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna-Elina Lehesjoki. Retrieved from https://idiyas.com/inventor/anna-elina-lehesjoki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Anna-Elina Lehesjoki

Introduction

Anna-Elina Lehesjoki is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of biotechnology, particularly through his work on Cystatin B mutants. With a focus on innovative solutions, he has secured a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

Anna-Elina Lehesjoki holds a patent for Cystatin B mutants. This invention represents a crucial step in understanding and potentially treating various medical conditions. His work in this area highlights the importance of genetic research and its applications in healthcare.

Career Highlights

Throughout his career, Anna-Elina has demonstrated a commitment to innovation and research. His work has not only contributed to his field but has also paved the way for future advancements in biotechnology. His patent is a testament to his skills and knowledge as an inventor.

Collaborations

Anna-Elina has collaborated with esteemed colleagues such as Richard M. Myers and David R. Cox. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Anna-Elina Lehesjoki is a distinguished inventor whose contributions to biotechnology are noteworthy. His patent for Cystatin B mutants exemplifies his innovative spirit and commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…